Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Nuvation Bio Inc. (NUVB) had Revenue of $83.23M for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	$83.23M
Net Income	$5.40M
Cost of Goods Sold	$5.99M
Gross Profit	$77.24M
Operating Expenses	$79.35M
Operating Income	$3.88M
Non-Operating Income/Expense	$1.52M
Pre-Tax Income	$5.40M
Normalized Pre-Tax Income	$5.40M
Income after Taxes	$5.40M
Income from Continuous Operations	$5.40M
Consolidated Net Income/Loss	$5.40M
Normalized Income after Taxes	$5.40M
EBIT	$3.88M
EBITDA	$4.74M
Weighted-Average Shares Outstanding (Basic)	347.33M
Weighted-Average Shares Outstanding (Diluted)	377.52M
Earnings per Share (EPS) (Basic)	$0.02
Earnings per Share (EPS) (Diluted)	$0.01
Balance Sheet Financials
Current Assets	$591.53M
Property, Plant, and Equipment	$0.54M
Long-Term Assets	$18.71M
Total Assets	$610.24M
Current Liabilities	$79.52M
Long-Term Debt	$47.33M
Long-Term Liabilities	$211.16M
Total Liabilities	$290.68M
Common Equity	$319.56M
Tangible Shareholders Equity	$308.81M
Shareholders Equity	$319.56M
Common Shares Outstanding	347.69M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$5.07M
Cash Flow from Investing Activities	$-43.64M
Cash Flow from Financial Activities	$0.04M
Beginning Cash	$164.09M
End Cash	$125.39M
Increase/Decrease in Cash	$-38.70M
Stock-Based Compensation	$9.03M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.44
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.17
Gross Margin	92.80%
Operating Margin	4.66%
EBIT Margin	4.66%
EBITDA Margin	--
Pre-Tax Profit Margin	6.48%
Profit Margin	6.48%
Free Cash Flow	$5.02M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.38
Receiveable Turnover	3.20
Days Sales in Receivables	28.10
Return on Equity	1.69%
Return on Tangible Equity	1.75%
Return on Assets	0.88%
Return on Investments	1.47%
Book Value Per Share	$0.92
Free Cash Flow per Share	$0.01
Operating Cash Flow per Share	$0.01

Data from Zacks Investment Research, Inc.